Across TCGA pan-cancer cohorts, LINC00269 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC00269’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC00269 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00269 is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.
KIRC, BLCA, and KIRP are the cancer types where LINC00269 tumor–normal differential expression is most reproducible.